DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) rose 2.91% to $134.32 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,428.78 and the Dow Jones Industrial Average rising 1.03% to 52,747.32.
This was the stock's second consecutive day of gains.
Gilead Sciences Inc. closed 14.60% below its 52-week high of $157.29, which the company reached on February 11th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.29% to $266.73, Pfizer Inc. $(PFE)$ rose 2.35% to $25.25, and Abbott Laboratories $(ABT)$ rose 2.66% to $107.27.
Trading volume (6.9 M) remained 791,879 below its 50-day average volume of 7.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 28, 2026.